Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 4/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.37 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.31 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | STS | P08842 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.30 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.30 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15021555 | 1.00 | CYP11B1 (0.37) | CYP11B1CYP11B2NR3C2DRD2DRD3 | |
| SCHEMBL15287108 | 1.00 | CYP11B1 (0.37) | CYP11B1CYP11B2NR3C2DRD2DRD3 | |
| SCHEMBL9274574 | 0.81 | CYP11B1 (0.38) | CYP11B1CYP11B2NR3C2DRD2DRD3 | |
| SCHEMBL18101342 | 0.78 | CYP11B1 (0.37) | CYP11B1CYP11B2NR3C2S1PR1S1PR2 | |
| SCHEMBL18094370 | 0.78 | KDM1A (0.41) | CYP11B1CYP11B2NR3C2POLLEPAS1 | |
| SCHEMBL16798270 | 0.78 | KDM1A (0.41) | CYP11B1CYP11B2NR3C2POLLEPAS1 | |
| SCHEMBL15287132 | 0.78 | MAP3K14 (0.34) | CYP11B1CYP11B2POLLMAP3K14STS | |
| SCHEMBL9282806 | 0.78 | HTR2A (0.40) | CYP11B1CYP11B2NR3C2DRD2DRD3 | |
| SCHEMBL15286837 | 0.77 | CYP11B1 (0.45) | CYP11B1CYP11B2NR3C2S1PR1 | |
| SCHEMBL1154471 | 0.77 | DRD2 (0.44) | CYP11B1CYP11B2NR3C2DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125359-A1 | HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS | FUJIAN HAIXI PHARMACEUTICALS CO LTD (CN) | 2026-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125359-A1 | HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS | ERBB2, ERBB3, ARRB1 | CYP11B1 644/4885CYP11B2 918/4885NR3C2 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.